Strauch Kimberly A
Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
AAOHN J. 2011 Dec;59(12):525-32; quiz 533. doi: 10.3928/08910162-20111123-01.
During the past decade, interest in the public and environmental health effects of trace levels of pharmaceuticals and personal care products in the water supply has evolved. Although most pharmaceuticals are tested for human safety and efficacy prior to marketing and distribution, the potential for adverse effects in nontarget populations exposed to minute environmental medication doses has not been established. Several recent studies have demonstrated adverse effects from longstanding, low-dose exposures in both aquatic and terrestrial wildlife, although human toxicity related to trace levels of pharmaceuticals in the water supply remains unknown. This article provides a brief overview of the routes through which pharmaceuticals are introduced into the environment; a description of the effects of longstanding, low-dose exposures in aquatic and terrestrial animals, including human health effects; an update on the current regulations and solutions regarding pharmaceutical disposal practices; and a discussion of implications for reducing pharmaceuticals in the environment for occupational health nurses and other allied health professionals.
在过去十年中,人们对供水系统中痕量药物和个人护理产品对公众健康和环境健康的影响的关注不断演变。尽管大多数药物在上市和分销前都经过了人体安全性和有效性测试,但对于接触微量环境药物剂量的非目标人群产生不良反应的可能性尚未确定。最近的几项研究表明,长期低剂量接触对水生和陆生野生动物都有不良影响,尽管与供水系统中痕量药物相关的人体毒性仍然未知。本文简要概述了药物进入环境的途径;描述了长期低剂量接触对水生和陆生动物的影响,包括对人类健康的影响;更新了有关药物处置做法的现行法规和解决方案;并讨论了减少环境中药物对职业健康护士和其他相关健康专业人员的影响。